VuFind

First trimester screening for Down syndrome

Tekijä: Niemimaa, Marko
Organisaatiot: University of Oulu, Faculty of Medicine, Department of Obstetrics and Gynaecology
Aineistotyyppi: e-kirja
URI: Kokoteksti (PDF, 0.8 MB)
Pysyvä osoite: http://urn.fi/urn:isbn:9514270290
Kieli: englanti
Julkaistu: 2003
Julkaisuaika: 2003-06-27
Opinnäytteen tyyppi: Väitöskirja
Väitöstiedote: Academic Dissertation to be presented with the assent of the Faculty of Medicine, University of Oulu, for public discussion in the Auditorium 4 of the University Hospital of Oulu, on June 27th, 2003, at 12 noon.
Tarkastaja(t): Docent Anna Alanen
Professor Pertti Kirkinen
Kuvaus:

Abstract

The aim of the present study was to evaluate the efficacy of the first trimester screening for Down syndrome (DS) in an unselected low-risk Finnish population. The study involved 4,617 women who attended screening between the 8th and 14th weeks of pregnancy in 1998-2000. They gave a blood sample for the measurement of pregnancy associated plasma protein A (PAPP-A) and free beta human chorionic gonadotrophin (β-hCG). Of these women, 3,178 also had an ultrasound examination for the measurement of fetal nuchal translucency (NT). The risk figure for every screened woman was calculated using a computerized risk figure program. The risk 1 in 250 was used as a cut-off. The subgroup of screen positives comprised 5.8% of the study group.

There were 16 DS cases. The combined method (maternal age, NT and the biochemical markers) detected 77% of the affected pregnancies. NT combined with maternal age gave a detection rate of 69%. Serum markers without NT combined with maternal age found 75% of the Down's.

In 49 consecutive singleton in-vitro-fertilization pregnancies, the β-hCG value was more often elevated compared to spontaneous pregnancies, increasing the false positive rate. In 67 twin pregnancies, the serum marker levels were approximately double those in singletons. Smoking reduced PAPP-A by 20% making the smokers more likely to get a positive screening result.

To determine the impact of the screening on the live born incidence of DS, two historical populations were compared. The first group was screened by second trimester serum samples (β-hCG and AFP) and the second group by first trimester ultrasound examination. When detection rates were at the same level, the second trimester screening reduced the number of live born Down's children more effectively.

In conclusion, the first trimester combined method (maternal age, NT, β-hCG and PAPP-A) for Down syndrome screening is efficient in an unselected low risk population. The biochemical screening is not recommended in IVF-pregnancies.

Sarja: Acta Universitatis Ouluensis. Series D, Medica (727)
ISSN: 0355-3221
ISSN-E: 1796-2234
ISBN: 951-42-7029-0
ISBN Print: 951-42-7028-2
Numero: 727
Aiheet: Down syndrome
beta-human chorionic gonadotropin
fertilization in vitro
first trimester of pregnancy
nuchal translucency
pregnancy
pregnancy-associated alpha-plasma protein
prenatal diagnosis
smoking
twin pregnancy
Tekijänoikeustiedot: Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.